CHRONIC LYMPHOCYTIC LEUKEMIA
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New immune cell attack tested for tough blood cancers
Disease control Not yet recruitingThis early-stage study is testing the safety of a new combination treatment for people with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior therapies. The treatment adds an experimental therapy—'natural killer' (NK) immune cells from a donor—…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE1 • Sponsor: Paolo Caimi, MD • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Five-Year safety check for promising blood cancer drug
Disease control Not yet recruitingThis study aims to monitor the long-term safety of the drug pirtobrutinib in people with previously treated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is open only to 150 participants who are already finishing a related earlier study, allowing them…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Pioneering cancer treatment trial launches in colombia
Disease control Not yet recruitingThis study has two main goals. First, it aims to set up the systems needed to make and deliver a type of personalized cell therapy called CAR-T in Colombia. Second, it will test the safety of this specific CAR-T therapy in a small group of adults with advanced blood cancers that …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: NA • Sponsor: GUSTAVO SALGUERO • Aim: Disease control
Last updated Mar 11, 2026 14:53 UTC
-
New combo therapy aims to free patients from lifelong cancer treatment
Disease control Not yet recruitingThis study is for older adults (65+) with untreated chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It compares a new, time-limited combination of two oral drugs (zanubrutinib and sonrotoclax) against taking one of the drugs continuously. The main goal is …
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC
-
Study exposes postcode lottery in blood cancer care
Knowledge-focused Not yet recruitingThis study aims to understand why patients with a common, slow-growing blood cancer (chronic lymphocytic leukemia, or CLL) receive different levels of care depending on where they live in the West Midlands region of the UK. Researchers will survey about 130 family doctors and spe…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Sponsor: The Royal Wolverhampton Hospitals NHS Trust • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Major study launches to track 2000 leukemia patients for decades
Knowledge-focused Not yet recruitingThis study aims to understand what factors influence long-term survival for people with chronic lymphocytic leukemia (CLL). It will follow 2,000 patients who previously received their first treatment in earlier German CLL Study Group trials. The goal is to collect real-world data…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:27 UTC